Applicability Across Genders and Conditions PT-141 is effective for: Men with erectile dysfunction, especially non-responders to PDE5 inhibitors Women diagnosed with hypoactive sexual desire disorder (HSDD) Individuals with underlying health issues like diabetes, hypertension, or neurological conditions Complementary Use with Other Therapies PT-141 is often used in combination with other treatments, such as PDE5 inhibitors or compounded therapies like Erexafil, to optimize sexual function from both vascular and neural pathways
doi:10.1080/1061186X.2024.2431316 148
All authors read and approved the final the manuscript
But theres a growing problem few are talking about: GLP-1 drugs alone rarely lead to sustainable, long-term metabolic health
Source : Tommi Raij, Kari Raij
In their separate trials, retatrutides top dose produced an average weight loss of 28.3%, compared with 20.7% for Wegovy 7.2 mg in STEP UP